December 2023
1. LI X, Sham PC, Zhang YD
   A Bayesian fine-mapping model using a continuous global-local shrinkage prior with applications in prostate cancer analysis.
   Am J Hum Genet. 2023 Dec 27:S0002-9297(23)00439.
   

   >> Share

   
   November 2023
2. VASSY JL, Brunette CA, Lebo MS, MacIsaac K, et al
   The GenoVA study: Equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary care.
   Am J Hum Genet. 2023;110:1841-1852.
   

   >> Share

   
   August 2023
3. TIAN Y, Dong D, Wang Z, Wu L, et al
   Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
   Am J Hum Genet. 2023;110:1289-1303.
   

   >> Share

   
   June 2023
4. DARST BF, Shen J, Madduri RK, Rodriguez AA, et al
   Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
   Am J Hum Genet. 2023 Jun 7:S0002-9297(23)00167.
   

   >> Share

   
   March 2022
5. SCHAID DJ, Sinnwell JP, Batzler A, McDonnell SK, et al
   Polygenic risk for prostate cancer: Decreasing relative risk with age but little impact on absolute risk.
   Am J Hum Genet. 2022 Mar 23. pii: S0002-9297(22)00104.
   

   >> Share

   
   November 2021
6. GIAMBARTOLOMEI C, Seo JH, Schwarz T, Freund MK, et al
   H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.
   Am J Hum Genet. 2021 Nov 22. pii: S0002-9297(21)00419.
   

   >> Share

   
   October 2021
7. SHETTY A, Seo JH, Bell CA, O'Connor EP, et al
   Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms.
   Am J Hum Genet. 2021 Oct 21. pii: S0002-9297(21)00344.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share